Karuna Therapeutics Management
Management criteria checks 1/4
Karuna Therapeutics' CEO is Bill Meury, appointed in Jan 2023, has a tenure of 1.17 years. directly owns 0.027% of the company’s shares, worth $3.41M. The average tenure of the management team and the board of directors is 1.1 years and 4.3 years respectively.
Key information
Bill Meury
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.2yrs |
| CEO ownership | 0.03% |
| Management average tenure | 1.1yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Karuna Therapeutics: Getting Sold Short
Feb 18We're Hopeful That Karuna Therapeutics (NASDAQ:KRTX) Will Use Its Cash Wisely
Sep 26
We're Not Very Worried About Karuna Therapeutics' (NASDAQ:KRTX) Cash Burn Rate
Jun 05Here's Why We're Not At All Concerned With Karuna Therapeutics' (NASDAQ:KRTX) Cash Burn Situation
Feb 20Karuna Therapeutics, Inc. (NASDAQ:KRTX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Nov 06Best Performing Stocks
Sep 23Karuna Therapeutics: This Ship Has Sailed
Sep 09Karuna Therapeutics GAAP EPS of -$2.17 misses by $0.10, revenue of $5.28M
Aug 08Karuna Therapeutics: Front-Running KarXT Phase 3
Jun 26Karuna Therapeutics (NASDAQ:KRTX) Is In A Good Position To Deliver On Growth Plans
May 10CEO
Bill Meury (55 yo)
1.2yrs
Tenure
Mr. William Meury, also known as Bill, served as a Partner at Hildred Capital Management LLC. He serves as Director at Crown Laboratories Inc and serves as its Chairman of the Board of Directors. He curren...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder and President of Research & Development | no data | US$5.77m | 0.037% $ 4.6m | |
| Chief Medical Officer | 7yrs | US$4.41m | 0.095% $ 11.9m | |
| President | 1.2yrs | no data | 0.027% $ 3.4m | |
| Chief Financial Officer | less than a year | no data | 0.037% $ 4.6m | |
| Vice President of Corporate Affairs & Investor Relations | no data | no data | no data | |
| General Counsel | 4.2yrs | no data | no data | |
| Senior Vice President of Corporate Development | less than a year | no data | no data | |
| Chief Human Resources Officer | less than a year | no data | no data | |
| Chair of Scientific Advisory Board & Chief Clinical Advisor | no data | no data | no data | |
| Senior Vice President of Medical | 3.2yrs | no data | no data | |
| Chief Commercial Officer | 1.1yrs | no data | 0.013% $ 1.6m |
1.1yrs
Average Tenure
57.5yo
Average Age
Experienced Management: KRTX's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.2yrs | no data | 0.027% $ 3.4m | |
| Chair of Scientific Advisory Board & Chief Clinical Advisor | no data | no data | no data | |
| Independent Director | 4.8yrs | US$336.10k | 0.085% $ 10.7m | |
| Director | 5.4yrs | US$326.60k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.3yrs | US$701.26k | no data | |
| Chairman | 3.9yrs | US$373.15k | 0% $ 0 | |
| Director & Member of Scientific Advisory Board | 6yrs | US$11.22m | 0.37% $ 47.0m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director & Member of Scientific Advisory Board | 4.8yrs | US$344.60k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.6yrs | US$345.10k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data |
4.3yrs
Average Tenure
69yo
Average Age
Experienced Board: KRTX's board of directors are considered experienced (4.3 years average tenure).